XML 33 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Millions
Total IBM Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Total IBM Stockholders' Equity
Common Stock and Additional Paid-in Capital
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income/(Loss)
Non-Controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at the Beginning of the Period at Dec. 31, 2019 $ (66) $ 20,841 $ 55,895 $ (66) $ 162,954 $ (169,413) $ (28,597) $ 144 $ (66) $ 20,985
Net income/(loss) plus other comprehensive income/(loss):                    
Net income   5,590     5,590         5,590
Other comprehensive income/(loss)   (740)         (740)     (740)
Total comprehensive income/(loss)   4,850               4,850
Cash dividends paid - common stock   (5,797)     (5,797)         (5,797)
Common stock issued under employee plans   661 661             661
Purchases and sales of treasury stock under employee plans - net   110     36 74       110
Changes in noncontrolling interests               (15)   (15)
Balance at the End of the Period at Dec. 31, 2020   20,597 56,556   162,717 (169,339) (29,337) 129   20,727
Net income/(loss) plus other comprehensive income/(loss):                    
Net income   5,743     5,743         5,743
Other comprehensive income/(loss)   4,839         4,839     4,839
Total comprehensive income/(loss)   10,582               10,582
Cash dividends paid - common stock   (5,869)     (5,869)         (5,869)
Common stock issued under employee plans   762 762             762
Purchases and sales of treasury stock under employee plans - net   (31)     22 (53)       (31)
Separation of Kyndryl   (7,140)     (8,404)   1,264 (62)   (7,203)
Changes in noncontrolling interests               28   28
Balance at the End of the Period at Dec. 31, 2021   18,901 57,319   154,209 (169,392) (23,234) 95   18,996
Net income/(loss) plus other comprehensive income/(loss):                    
Net income   1,639     1,639         1,639
Other comprehensive income/(loss)   6,494         6,494     6,494
Total comprehensive income/(loss)   8,134               8,134
Cash dividends paid - common stock   (5,948)     (5,948)         (5,948)
Common stock issued under employee plans   962 962             962
Purchases and sales of treasury stock under employee plans - net   (104)     (12) (92)       (104)
Other equity   0 63   (63)         0
Changes in noncontrolling interests               (18)   (18)
Balance at the End of the Period at Dec. 31, 2022   $ 21,944 $ 58,343   $ 149,825 $ (169,484) $ (16,740) $ 77   $ 22,021